Variant report

Variant	esv2763045
Chromosome Location	chr13:87005617-87079364
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:0)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK6-13	chr13:87065819-87066011	NONHSAT034578
2	lnc-SLITRK6-13	chr13:87065395-87066011	l_895_chr13:87064439-87121529_brain
3	lnc-SLITRK6-13	chr13:87064440-87065323	l_895_chr13:87064439-87121529_brain
4	lnc-SLITRK6-13	chr13:87035114-87035336	NONHSAT034577
5	lnc-SLITRK6-13	chr13:87065819-87066011	NONHSAT034577
6	lnc-SLITRK6-13	chr13:87071264-87071414	NONHSAT034578

No data

Extended variants
information (count: 1411 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:1411 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9590326	chr13:87005617-87005618	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs553113323	chr13:87005706-87005707	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs578018524	chr13:87005719-87005720	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs538764040	chr13:87005727-87005728	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs181290760	chr13:87005781-87005782	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs576301159	chr13:87005792-87005793	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs578042752	chr13:87005823-87005824	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs149984486	chr13:87005858-87005859	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs369800243	chr13:87005862-87005863	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs540988634	chr13:87005887-87005888	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs185924311	chr13:87005952-87005953	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs532998370	chr13:87005970-87005971	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs551187875	chr13:87005971-87005972	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs563806691	chr13:87005979-87005980	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs563441274	chr13:87006061-87006062	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs67787923	chr13:87006134-87006135	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs144070189	chr13:87006152-87006153	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs567588772	chr13:87006171-87006172	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs528774385	chr13:87006213-87006214	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs114193849	chr13:87006269-87006270	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs571552230	chr13:87006283-87006284	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs146535426	chr13:87006298-87006299	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs557165628	chr13:87006305-87006306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs9284287	chr13:87006316-87006317	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs537219953	chr13:87006345-87006346	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs141132524	chr13:87006359-87006360	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs143455941	chr13:87006404-87006405	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs540970675	chr13:87006434-87006435	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs553280058	chr13:87006442-87006443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs146735519	chr13:87006445-87006446	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs545025878	chr13:87006484-87006485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs563024716	chr13:87006488-87006489	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs371364592	chr13:87006510-87006511	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs374802071	chr13:87006534-87006535	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs79557148	chr13:87006549-87006550	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs542776528	chr13:87006560-87006561	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs78958909	chr13:87006565-87006566	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs528711171	chr13:87006572-87006573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs546974002	chr13:87006573-87006574	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs571390007	chr13:87006623-87006624	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs571948056	chr13:87006653-87006654	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs67165923	chr13:87006659-87006660	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs72638841	chr13:87006685-87006686	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs1814137	chr13:87006695-87006696	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs539475761	chr13:87006727-87006728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs568952027	chr13:87006776-87006777	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs182273631	chr13:87006811-87006812	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs536227997	chr13:87006820-87006821	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs567466126	chr13:87006839-87006840	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs143518026	chr13:87006858-87006859	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Prostate cancer	18632612	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Non-small cell lung cancer	16651412	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Osteosarcoma	21215367	CNVD

Chromatin state (count:82 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:87004600-87005800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr13:87004600-87009800	Weak transcription	HUES48 Cell Line	embryonic stem cell
3	chr13:87005800-87008000	Enhancers	ES-I3 Cell Line	embryonic stem cell
4	chr13:87006200-87006600	Enhancers	H9 Cell Line	embryonic stem cell
5	chr13:87006200-87006600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
6	chr13:87006400-87007000	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr13:87006400-87007600	Enhancers	HUES6 Cell Line	embryonic stem cell
8	chr13:87006600-87011200	Weak transcription	H9 Cell Line	embryonic stem cell
9	chr13:87007000-87009800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
10	chr13:87007600-87009600	Weak transcription	HUES6 Cell Line	embryonic stem cell
11	chr13:87008000-87008400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
12	chr13:87008400-87009400	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr13:87008800-87009800	Enhancers	Fetal Lung	lung
14	chr13:87009400-87009600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
15	chr13:87009600-87014000	Active TSS	HUES6 Cell Line	embryonic stem cell
16	chr13:87009600-87014400	Active TSS	ES-I3 Cell Line	embryonic stem cell
17	chr13:87009800-87010200	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr13:87009800-87010200	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr13:87010200-87010800	Weak transcription	HUES48 Cell Line	embryonic stem cell
20	chr13:87010200-87015600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
21	chr13:87010800-87011600	Active TSS	HUES48 Cell Line	embryonic stem cell
22	chr13:87011200-87012400	Active TSS	H9 Cell Line	embryonic stem cell
23	chr13:87011600-87015400	Weak transcription	HUES48 Cell Line	embryonic stem cell
24	chr13:87012400-87017800	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr13:87014000-87014200	Transcr. at gene 5' and 3'	HUES6 Cell Line	embryonic stem cell
26	chr13:87014200-87014400	Genic enhancers	HUES6 Cell Line	embryonic stem cell
27	chr13:87014400-87016200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
28	chr13:87014400-87016400	Weak transcription	HUES6 Cell Line	embryonic stem cell
29	chr13:87015400-87015600	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr13:87015600-87016000	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr13:87015600-87016000	Enhancers	iPS-15b Cell Line	embryonic stem cell
32	chr13:87016000-87016200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
33	chr13:87016000-87016400	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr13:87016200-87016400	Active TSS	ES-I3 Cell Line	embryonic stem cell
35	chr13:87016200-87016800	Enhancers	H1 Cell Line	embryonic stem cell
36	chr13:87016200-87016800	Enhancers	iPS-15b Cell Line	embryonic stem cell
37	chr13:87016400-87016600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
38	chr13:87016400-87016800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
39	chr13:87016400-87016800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
40	chr13:87016400-87016800	Enhancers	HUES64 Cell Line	embryonic stem cell
41	chr13:87016400-87016800	Enhancers	iPS-20b Cell Line	embryonic stem cell
42	chr13:87016600-87016800	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr13:87016800-87017200	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr13:87016800-87017400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
45	chr13:87016800-87017600	Weak transcription	HUES6 Cell Line	embryonic stem cell
46	chr13:87016800-87017800	Weak transcription	H1 Cell Line	embryonic stem cell
47	chr13:87017400-87018000	Genic enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr13:87017600-87018200	Genic enhancers	HUES6 Cell Line	embryonic stem cell
49	chr13:87017800-87018000	Enhancers	H1 Cell Line	embryonic stem cell
50	chr13:87017800-87018000	Enhancers	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links